Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
5.69
+0.04 (0.62%)
At close: Jan 21, 2025, 4:00 PM
5.85
+0.16 (2.81%)
After-hours: Jan 21, 2025, 5:24 PM EST
Monte Rosa Therapeutics Market Cap
Monte Rosa Therapeutics has a market cap or net worth of $349.57 million as of January 21, 2025. Its market cap has increased by 22.08% in one year.
Market Cap
349.57M
Enterprise Value
157.53M
1-Year Change
22.08%
Ranking
Category
Stock Price
$5.69
Market Cap Chart
Since the IPO on June 24, 2021, Monte Rosa Therapeutics's market cap has decreased from $845.31M to $349.57M, a decrease of -58.65%. That is a compound annual growth rate of -21.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 17, 2025 | 347.42M | -18.52% |
| Dec 31, 2024 | 426.37M | 50.74% |
| Dec 29, 2023 | 282.85M | -23.21% |
| Dec 30, 2022 | 368.32M | -61.22% |
| Dec 31, 2021 | 949.65M | 12.34% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |